Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (361-370 of 393) with videos related to

Pageof 40
Sort By:
Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|March 9, 2017
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseasesGerasimos S Filippatos, Pieter de Graeff, Jeroen J Bax, et al.
JAMA Psychiatry|June 4, 2025
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical TrialChristian Otte, Woo Ri Chae, Deniz Yildirim Dogan, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 16, 2026
Design and Rationale of the WE-CARE-HF-CMR Trial: Cardiorenal Care on Wheels for Asymptomatic Heart Failure Patients (NCT07185100)Jeffrey Ji-Peng Li, Gisela Thiede, Collin Götze, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
The New England Journal of Medicine|May 27, 2026
Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart FailureWolfram-Hubertus Zimmermann, Stephan Ensminger, Ingo Kutschka, et al.
ESC Heart Failure|March 12, 2023
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort studyChristine Zelenak, Jonas Nagel, Kristina Bersch, et al.
Clinical and Translational Radiation Oncology|April 25, 2025
ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study GroupHendrik Dapper, Maximilian Fleischmann, Nikolaos Tselis, et al.
Pageof 40

Showing results (361-370 of 393) with videos related to

Sort By:
Pageof 40
Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|March 9, 2017
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseasesGerasimos S Filippatos, Pieter de Graeff, Jeroen J Bax, et al.
JAMA Psychiatry|June 4, 2025
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical TrialChristian Otte, Woo Ri Chae, Deniz Yildirim Dogan, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 16, 2026
Design and Rationale of the WE-CARE-HF-CMR Trial: Cardiorenal Care on Wheels for Asymptomatic Heart Failure Patients (NCT07185100)Jeffrey Ji-Peng Li, Gisela Thiede, Collin Götze, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
The New England Journal of Medicine|May 27, 2026
Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart FailureWolfram-Hubertus Zimmermann, Stephan Ensminger, Ingo Kutschka, et al.
ESC Heart Failure|March 12, 2023
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort studyChristine Zelenak, Jonas Nagel, Kristina Bersch, et al.
Clinical and Translational Radiation Oncology|April 25, 2025
ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study GroupHendrik Dapper, Maximilian Fleischmann, Nikolaos Tselis, et al.
Pageof 40